SCIENTIFIC AND INFORMATION-ANALYTICAL MAGAZINE

ISSN 1024-6177 (Print), ISSN 2618-9615 (Online)

JOURNAL DESCRIPTION

The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.

Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.

Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.

The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.

Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.

The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.

Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.

The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.

Issues journals

Medical Radiology and Radiation Safety. 2016. Vol. 61. No. 1. P. 47-59

REVIEW

G.E. Roytberg1, S.V. Usychkin1, A.V. Boiko2

Extreme Hypofractionated external-Beam radiotherapy for Prostate Cancer

1. JSC “Medicina”, Moscow, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. ; 2. P.A.Herzen Moscow Scientific-Research Oncological Institute, Moscow, Russia

ABSTRACT

Hypofractionation is one of the approaches in the non-classical fractionation of prostate cancer external-beam radiotherapy. The purpose of hypofractionation is not only to make the treatment more comfortable for the patient (less daily visits to the treatment center) and more cost-effective but also to increase the local tumor control as well. High dose per fraction increases a biologically effective dose for prostate adenocarcinoma cells and works as a biological radiosensitizer while isoeffective dose for normal tissues remains unchanged. In 80-90 % of patients with localized prostate cancer treated with extremely hypofractionated radiotherapy (7 to 8 Gy dose per fraction, 5 fractions to the total dose of 35-40 Gy) a permanent biochemical tumor control is achieved. The modern high-precision treatment planning and treatment delivery techniques (IMRT, VMAT) as well as on-line target tracking and image guidance (IGRT) coupled with additional systems of internal prostate immobilization (endorectal balloons and «spacers» inserted between prostate and rectal wall) are prerequisite conditions for extreme hypofractionated radiotherapy. Completed recently multiple studies of phase 2 have demonstrated that extremely hypofractionated prostate radiotherapy did not increase the rate of serious late toxicity if it is performed in the clinics with high level of modern technical equipment Image-Guided Radiotherapy. For this reason it can be used as an alternative to the conventionally fractionated radiotherapy.

Key words: external-beam radiotherapy, extreme fractionation, prostate cancer, hypofractiotion

REFERENCES

  1. Tarinskii V.V., Petrova G.V. Zlokachestvennye novoobrazovaniya v Rossii v 2012 godu (zabolevaemost' i smertnost'). Moscow: FGBU «MNIOI im. P.A. Gertsena» Minzdrava Rossii. 2014. 250 p. (In Russ.).
  2. D’Amico A.V., Whittington R., Malkowicz S.B. et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer. 2002. Vol. 95. No. 2. P. 281-286.
  3. D’Amico A.V., Whittington R., Malkowicz S.B. et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J. Clin. Oncol. 1999. Vol. 17. No. 1. P. 168-172.
  4. D’Amico A.V. Prostate cancer: where we have been. where we are. and where we are going. Semin Radiat. 2013. Vol. 23. No. 3. P. 155-156.
  5. Peeters S.T., Heemsbergen W.D., Koper P.C. et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J. Clin. Oncol. 2006. Vol. 24. No. 13. P. 1990-1996.
  6. Pollack A., Zagars G.K., Starkschall G. et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int. J. Radiat. Biol. Phys. 2002. Vol. 53. No. 5. P. 1097-1105.
  7. Zietman A.L., DeSilvio M.L., Slater J.D. et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005. Vol. 294. No. 10. P. 1233-1239.
  8. Spratt D.E., Pei X., Yamada J. et al. Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. Int. J. Radiat. Biol. Phys. 2013. Vol. 85. No. 3. P. 686-692.
  9. Dar'yalova S.L., Boiko A.V., Alekseev B.Ya., Grishina Yu.A. Metodika i rezul'taty luchevoi terapii raka predstatel'noi zhelezy. Ross. onkol. zhurnal. 2006. No. 6. P. 9-13. (In Russ.).
  10. Boiko A.V., Chernichenko A.V., Dar'yalova S.L., Meshcheryakova I.A., Ter-Arutyunyants S.A. Netraditsionnoe fraktsionirovanie dozy. V sb. «Materialy V Rossiiskoi onkologicheskoi konferentsii». 2001.
  11. Chernichenko A.V., Boiko A.V., Morozova S.V. et al. Termoradioterapiya raka predstatel'noi zhelezy. Ross. onkol. zhurnal. 2009. No. 3. P. 9-12. (In Russ.).
  12. Miles E.F., Lee W.R. Hypofractionation for prostate cancer: a critical review. Semin. Radiat. Oncol. 2008. Vol. 18. No. 1. P. 41-47.
  13. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. 1999. Vol. 43. No. 5. P. 1095-1101.
  14. Vogelius I.R., Bentzen S.M. Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news. good news. or no news?. Int. J. Radiat. Oncol. Phys. 2013. Vol. 85. No. 1. P. 89-94.
  15. Fowler J.F., Toma-Dasu I., Dasu A. Is the alpha/beta ratio for prostate tumours really low and does it vary with the level of risk at diagnosis? Anticancer Res. 2013. Vol. 33. No. 3. P. 1009-1011.
  16. Tree A.C., Khoo V.S., van As N.J. et al. Is biochemical relapse-free survival after profoundly hypofractionated radiotherapy consistent with current radiobiological models? Clin. (R. Coll. Radiol.). 2014. Vol. 26. No. 4. P. 216-229.
  17. Kupelian P.A., Willoughby T.R., Reddy C.A. et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int. J. Radiat. Biol. Phys. 2007. Vol. 68. No. 5. P. 1424-1430.
  18. Yeoh E.E., Botten R.J., Butters J. et al. Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial. Int. J. Radiat. Biol. Phys. 2011. Vol. 81. No. 5. P. 1271-1278.
  19. Dearnaley D., Syndikus I., Sumo G. et al. Conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomized controlled trial. Lancet Oncol. 2012. Vol. 13. No. 1. P. 43-54.
  20. Arcangeli G., Saracino B., Gomellini S. et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int. J. Radiat. Biol. Phys. 2010. Vol. 78. No. 1. P. 11-18.
  21. Arcangeli S., Strigari L., Gomellini S. et al. Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int. J. Radiat. Biol. Phys. 2012. Vol. 84. No. 5. P. 1172-1178.
  22. Arcangeli G., Fowler J., Gomellini S. et al. Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 79. No. 4. P. 1013-1021.
  23. Arcangeli S., Scorsetti M., Alongi F. Will SBRT replace conventional radiotherapy in patients with low intermediate risk prostate cancer? A review. Crit Rev Oncol Hematol. 2012. Vol. 84. No. 1. P. 101-108.
  24. Buyyounouski M.K., Price R.A., , Harris E.E. et al. Stereotactic body radiotherapy for primary management of early-stage. low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 76. No. 5. P. 1297-1304.
  25. Ishiyama H., Teh B.S., Lo S.S. et al. Stereotactic body radiation therapy for prostate cancer. Future Oncol. 2011. Vol. 7. No. 9. P. 1077-1086.
  26. Fuks Z., Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005. Vol. 8. No. 2. P. 89-91.
  27. Collins C.D., Lloyd-Davies R.W., Swan A.V. Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin. (R. Coll. Radiol.). 1991. Vol. 3. No. 3. P. 127-132.
  28. Martinez A.A., Demanes J., Vargas C. et al. High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer. Amer. J. Clin. 2010. Vol. 33. No. 5. P. 481-488.
  29. King C.R., Lehmann J., Adler J.R. et al. CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol. Cancer Res. Treat. 2003. Vol. 2. No. 1. P. 25-30.
  30. Fuller D.B., Naitoh J., Lee C. et al. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int. J. Radiat. Biol. Phys. 2008. Vol. 70. No. 5. P. 1588-1597.
  31. King C.R., Brooks J.D., Gill H. et al. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int. J. Radiat. Biol. Phys. 2009. Vol. 73. No. 4. P. 1043-1048.
  32. King C.R., Brooks J.D., Gill H. et al. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int. J. Radiat. Biol. Phys. 2012. Vol. 82. No. 2. P. 877-882.
  33. Katz A.J., Santoro M., Diblasio F. et al. Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat. 2013. Vol. 8. No. 1. P. 1-8.
  34. King C .R., Freeman D., Kaplan I. et al. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother. Oncol. 2013. Vol. 109. No. 2. P. 217-221.
  35. Madsen B.L., Hsi R.A., Pham H.T. et al. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP). 33.5 Gy in five fractions for localized disease: first clinical trial results. Int. J. Radiat. Biol. Phys. 2007. Vol. 67. No. 4. P. 1099-1105.
  36. Friedland J.L., Freeman D.E., Masterson-McGary M.E. et al. Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol. Cancer Res. Treat. 2009. Vol. 8. No. 5. P. 387-392.
  37. Boike T.P., Lotan Y., Cho L.C. et al. Phase I dose-escalation study of stereotactic body radiation therapy for lowand intermediate-risk prostate cancer. J. Clin. Oncol. 2011. Vol. 29. No. 15. P. 2020-2026.
  38. Kang J.K., Cho C.K., Choi C.W. et al. Image-guided stereotactic body radiation therapy for localized prostate cancer. Tumori. 2011. Vol. 97. No. 1. P. 43-48.
  39. McBride S.M., Wong D.S., Dombrowski J.J. et al. Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial. Cancer. 2012. Vol. 118. No. 15. P. 3681-3690.
  40. Bolzicco G., Favretto M.S., Satariano N. et al. A singlecenter study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy. BMC Urol. 2013. Vol. 13. No. 1. P. 1-8.
  41. Chen L.N., Suy S., Uhm S. et al. Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Radiat. 2013. Vol. 8. No. 1. P. 1-10.
  42. Aluwini S., van Rooij P., Hoogeman M. et al. Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results. Radiat. 2013. Vol. 8. No. 1. P. 1-7.
  43. Oliai C., Lanciano R., Sprandio B. et al. Stereotactic body radiation therapy for the primary treatment of localized prostate cancer. J. Radiat. Oncol. 2013. Vol. 2. No. 1. P. 63-70.
  44. Loblaw A., Cheung P., D’Alimonte L. et al. Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity. biochemical. and pathological outcomes. Radiother. 2013. Vol. 107. No. 2. P. 153-158.
  45. Tree A., Aluwini S., Bryant H. et al. Successful Patient Acceptance of Randomization Within the Pace Study (Prostate Advances in Comparative Evidence). Int. J. Radiat. Oncol. Biol. Phys. 2013. Vol. 87. No. 2. P. S365.
  46. Mohler J.L., Kantoff P.W., Armstrong A.J. et al. Prostate cancer. version 2. 2014. J. Natl. Compr. Canc. Netw. 2014. Vol. 12. No. 5. P. 686-718.
  47. Greco C. Extreme hypofractionated image-guided radiotherapy for prostate cancer. EMJ Oncol. 2013. No. 1. P. 48-55.
  48. Mok G., Benz E., Vallee J.P. et al. Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: a systematic review. Int. J. Radiat. Biol. Phys. 2014. Vol. 90. No. 2. P. 278-288.
  49. Sumila M., Mack A., Schneider U. et al. Long-term intrafractional motion of the prostate using hydrogel spacer during Cyberknife(R) treatment for prostate cancer a case report. Radiat. 2014. Vol. 9. No. 1. P. 1-6.
  50. Chapet O., Udrescu C., Tanguy R. et al. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy. Int. J. Radiat. Biol. Phys. 2014. Vol. 88. No. 2. P. 425-432.
  51. Wei J.T., Dunn R.L., Litwin M.S. et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000. Vol. 56. No. 6. P. 899-905.
  52. Szymanski K.M., Wei J.T., Dunn R.L. et al. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring healthrelated quality of life among prostate cancer survivors. Urology. 2010. Vol. 76. No. 5. P. 1245-1250.
  53. King C.R., Collins S., Fuller D. et al. Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials. Int. J. Radiat. Biol. Phys. 2013. Vol. 87. No. 5. P. 939-945.
  54. Arscott W.T., Chen L.N., Wilson N. et al. Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer. Radiat. 2014. Vol. 9. No. 1. P. 163-172.
  55. Woo J.A., Chen L.N., Bhagat A. et al. Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer. Fronties in Oncol. 2014. Vol. 4. No. 1. P. 1-10.
  56. Chen L.N., Suy S., Wang H. et al. Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer. Radiat. 2014. Vol. 9. No. 1. P. 1-9.
  57. Sood S., Ju A.W., Wang H. et al. Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer. Radiat. 2013. Vol. 8. No. 1. P. 1-6.
  58. Kim D.W., Cho L.C., Straka C. et al. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int. J. Radiat. Biol. Phys. 2014. Vol. 89. No. 3. P. 509-517.
  59. Wiegner E.A., King C.R. Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 78. No. 2. P. 442-448.

For citation: Roytberg GE, Usychkin SV, Boiko AV. Extreme Hypofractionated External-Beam Radiotherapy for Prostate Cancer. Medical Radiology and Radiation Safety. 2016;61(1):47-59. Russian.

PDF (RUS) Full-text article (in Russian)

Medical Radiology and Radiation Safety. 2016. Vol. 61. No. 1. P. 41-46

DIAGNOSTIC RADIOLODGY

N.S. Vorotyntseva, M.Yu. Zozulya

Ultrasonic Morphometric Age Standards of Abdominal Parenchymatous Organs of the Children Living in the Area of Kursk NPP

Kursk State Medical University, Kursk, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

ABSTRACT

Purpose: To define the individual ultrasonic morphometric age standards of the abdominal parenchymatous organs of the children living in the area of Kursk NPP.

Material and methods: The results are presented of ultrasonic examinations of 400 children at the age from 1 year to 17 years 11 months who are living in the area of Kursk NPP. The assessment of the lengths of the right kidney and oblique transverse dimension of the right lobe of the liver & the length of the left kidney and the length of the spleen depending on the age and sex of investigated was produced.

Results: Mathematical models and formulas have been developed for calculating standard ultrasonic morphometric parameters, annual growth of morphometric dimensions of abdominal parenchymatous organs was defined. Moreover, individual regulatory criteria for diagnosis hepatosplenomegaly was developed during the comparison of the length of the right kidney with oblique transverse dimension of the right liver lobe and the length of the left kidney with the length of the spleen .

Conclusion: The obliquely-transverse size of the liver right lobe must match the length of the right kidney as 1:1 for children between 3 and 11 years of age, the length of the spleen corresponds to the left kidney length as 1:1 for children between 2 and 11 years of age. The liver and spleen sizes of those children who are older than 12 should not exceed the length of the right and left kidneys respectively. In addition, it was shown that Kursk NPP operating normally has no negative impact on the formation and development of abdominal parenchymal organs in children and adolescents.

Key words: pediatric ultrasound, age standards, abdominal parenchymatous organs, Kursk NPP, territory of residence

REFERENCES

  1. Lyaginskaya A.M., Romanov V.V. et al. Sostoyanie zdorov'ya naseleniya, prozhivayushchego vblizi Smolenskoi AES. Medical Radiology and Radiation Safety. 2015. Vol. 60. No. 2. P. 25-36. (In Russ.).
  2. Shandala N.K., Korenkov I.P., Romanov V.V. Sostoyanie radiatsionno-gigienicheskoi obstanovki v raione razmeshcheniya AES. Medical Radiology and Radiation Safety. 2015. Vol. 60. No. 2. P.15-21. (In Russ.).
  3. Federal'nyi zakon Rossiiskoi Federatsii ot 21 noyabrya 2011 g. No. 323-FZ «Ob osnovakh okhrany zdorov'ya grazhdan v Rossiiskoi Federatsii». St. 7. (In Russ.).
  4. Vasil'ev A.Yu., Vyklyuk M.V., Zubareva E.A. et al. Luchevaya diagnostika v pediatrii: natsional'noe rukovodstvo. Moscow: GEOTAR-Media. 2010. 368 p. (In Russ.).
  5. Trufanov G.E., Fokin V.A. et al. Osobennosti primeneniya metodov luchevoi diagnostiki v pediatricheskoi praktike. Vestnik sovremennoi klinich. med. 2013. Vol. 6. No. 6. P. 48-54. (In Russ.).
  6. Bates A.J. Abdominal Ultrasound. How, why and when. 2 ed. Churchill Livingstone. 2004. 297 p. (In Russ.).
  7. Dvoryakovskii I.V., Naidina T.K., Sugak A.B. et al. Vozrastnye parametry pochek u detei po dannym ul'trazvukovogo issledovaniya. Ul'trazvukovaya i funktsional'naya diagnostika. 2004. No. 1. P. 30-35. (In Russ.).
  8. Naidina T.K., Dvoryakovskii I.V., Sugak A.B. Normal'nye vozrastnye razmery zhelchnogo puzyrya. pecheni i podzheludochnoi zhelezy u detei po dannym ekhografii. Ul'trazvukovaya i funktsional'naya diagnostika. 2001. No. 4. P. 57-63. (In Russ.).
  9. Sumenko V.V., Vozgoment O.V., Pykov M.I. Normativnye ekhograficheskie pokazateli selezenki u zdorovykh detei Orenburgskoi oblasti i faktory, vliyayushchie na nikh. Detskaya bol'nitsa. 2013. No. 2. P. 16-22. (In Russ.).
  10. Trefilov A.A., Ivanova I.E., Rodionov V.A. Ul'trazvukovye normativy razmerov pochek u detei Chuvashskoi Respubliki. Zdravookhranenie Chuvashii. 2011. No. 4. Available from: http://giduv.com/journal/2011/4/ultrazvukovye_normativy (accessed: 15.06.2015). (In Russ.).
  11. Bruyn R. Pediatric ultrasound: how, why and when. Edinburgh: Elsevier. 2005. 374 p.
  12. Blok B. Tsvetnoi atlas ul'trazvukovykh issledovanii. Moscow: MEDpress-inform. 2013. 328 p. (In Russ.).
  13. Vorotyntseva N.S., Zozulya M.Yu., Zozulya A.Yu. Sposob ul'trazvukovoi diagnostiki vospalitel'nykh izmenenii pecheni i selezenki pri tuberkuleze u detei. / Patent na izobretenie No. 2535613 ot 05.11.2013 g. Postupila: 25.06.2015 (In Russ.).

For citation: Vorotyntseva NS, Zozulya MYu. Ultrasonic Morphometric Age Standards of Abdominal Parenchymatous Organs of the Children Living in the Area of Kursk NPP. Medical Radiology and Radiation Safety. 2016;61(1):41-6. Russian.

PDF (RUS) Full-text article (in Russian)

Medical Radiology and Radiation Safety. 2016. Vol. 61. No. 1. P. 29-33

RADIATION MEDICINE

N.A. Metlyaeva, O.V. Scherbatich

Features of Social Adaptation of Participants of the Accident on the Nuclear Submarines K-19 and K-27 According to Psychophysiological Inspection

A.I. Burnasyan Federal Medical Biophysical Center of FMBA, Moscow, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

ABSTRACT

Purpose: To evaluate the personal and current mental status of three participants of the accident on the nuclear submarine K19 (F.U.P) and K27 (R.A.S. and F.A.M.) according to psychophysiological examination.

Material and methods: The results are shown of the psychophysiological examination of three participants of the accident on the nuclear submarine K19 in 1961 (04.07.61) and K27 in 1968 (24.05.68), where the operator of a reactor lieutenant F.U.P. at the age of 23 (year of birth: 1938) had the ARS of the first degree of severity (dose on EPR tooth enamel 1.14 ± 0.10 Gy), sergeant R.A.S. at the age of 23 (year of birth: 1945) had the ARS of the third degree of severity (dose on EPR tooth enamel 3.6-4.0 Gy), a dosimetrist F.A.M. at the age of 22 (year of birth: 1946) had the ARS of the second degree of severity (dose on EPR tooth enamel 1.12 ± 0.05 Gy) from the combined gamm-abeta radiation. Three patients underwent clinical and psychophysiological examination in 2002-2014 at the age of 57 and 56. All three patients were diagnosed with psychosomatic pathology hypertension of the second degree, while F.A.M. had a higher indices of hypertension (BP = 150/90, 140/100 and 200/100 mm Hg). R.A.S. had coronary heart disease, stenocardia, FC II-II and F.A.M. had FC II F.U.P. had diabetes mellitus type 2, insulin dependent form, decompensation, F.A.M. had chronic bronchitis, pneumosclerosis.

Results: The rise of the indicators of MMPI profile above 80 T-points on the scale of 1, 2, 6, 8 and F of both neurological and psychological triad, indicates the mental stress adaptation in three participants of the accident. Major general stress factor of psychophysiological adaptation was caused by protracting the acknowledgement of the victims to be the disable people due to the diseases, connected with the direct participation in the action of the special risk subunit (F.A.M. was recognized after 27 years, R.A.C. after 37 years, F.U.P. 38 years after radiation accident). A positive solution on the issue of indexation of the pension to F.A.M. in the court . resulted in a significant positive dynamics of psychological data in a gradual reduction of the indiceses, characterizing the severity of affective rigidity, fear and self-doubt, original thinking (scale: 6, 7, 8 respectively), the level of anxiety (scale: 2, 9, F, 0), with the maintenance of considerable severity of hypochondriac tendencies, the deterioration of which was due to the long judicial process (during 6 years). Labor activity of R.A.S. was the most favorable condition for the realization of his needs, and his adaptation was full, he could become a very useful member of society.

Conclusions: Patient P.A.S. had ARS of more severe degree (ARS III) than F.A.M. and F.U.P. Despite this fact, the setting and the motivation to work has allowed him to live an active lifestyle, to have a lesser degree of reduction of efficiency of the social adaptation and a less pronounced psychosomatic pathology.

Key words: submarines, radiation accidents, acute radiation disease, social adaptation, hypertensive disease, ischemic heart disease

REFERENCES

  1. Gus'kova A.K. Bolezn' i lichnost' bol'nogo. Vrach. 2003. No. 5. P. 57-58. (In Russ.).
  2. Lartsev M.A. Psikhofiziologicheskoe obespechenie professional'nykh kontingentov, uchastvuyushchikh v likvidatsii chrezvychainykh situatsii (metodologiya i organizatsiya). Avtorefer. diss. dokt. med. nauk. Moscow: 1998. 34 p. (In Russ.).
  3. Liberman A.N. Radiatsiya i stress. Sotsial'no-psikhologicheskie posledstviya Chernobyl'skoi avarii. Saint Petersburg: 2002. 160 p. (In Russ.).
  4. Martens V.K., Bobrov A.F., Sorokin A.V. et al. Prognozirovanie professional'noi nadezhnosti operativnogo personala Balakovskoi AES. rekomendatsii. Moscow: 1999. 20 p. (In Russ.).
  5. Preobrazhenskii V.N., Ushakov I.B., Lyadov K.V. Aktivatsionnaya terapiya v sisteme meditsinskoi reabilitatsii lits opasnykh professii. Moscow: Paritet Graf. 2000. 320 p. (In Russ.).
  6. Sushkevich A.G. Stress-indutsirovannye faktory riska nevroticheskikh rasstroistv i ratsional'nye podkhody k povysheniyu indeksa kachestva zhizni u likvidatorov posledstvii avarii na Chernobyl'skoi AES. kand. med. nauk. Moscow: 2006. 135 p. (In Russ.).
  7. Ushakov I.B., Karpov V.N. Mozg i radiatsiya (k 100letiyu radioneirobiologii). Moscow: GNIII aviats. i kosmich. meditsiny. 1997. 75 p. (In Russ.).

For citation: Metlyaeva NA, Scherbatich OV. Features of Social Adaptation of Participants of the Accident on the Nuclear Submarines K-19 and K-27 According to Psychophysiological Inspection. Medical Radiology and Radiation Safety. 2016;61(1):29-33. Russian.

PDF (RUS) Full-text article (in Russian)

Medical Radiology and Radiation Safety. 2016. Vol. 61. No. 1. P. 34-40

RADIATION MEDICINE

Yu.V. Semenova1,2, A.B. Karpov1,3, R.M. Takhauov1,3, E.G. Borisova1, D.E. Maximov1,3, A.B. Trivozhenko1, E.V. Kovalchuk1

Structural and Functional Changes of Vascular System in Individuals Exposed to Occupational Irradiation of Low Intensity

1. Seversk Biophysical Research Center of the FMBA of Russia, Seversk, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it. ; 2. Siberian Federal Research and Clinical Center of the FMBA of Russia, Seversk, Russia; 3. Siberian State Medical University, Tomsk, Russia

ABSTRACT

Purpose: To study the condition of vascular system in employees of nuclear industry exposed to long-term occupational irradiation in a range of low doses.

Material and methods: The object of study is the group of employees of the Siberian Chemical Enterprises, exposed to long-term occupational irradiation (n = 93). Among the employees (44-45 years old) a group of individuals, whose duration of occupational activity was not less than 3 years, was formed by means of randomization. For each person the 65 parameters including the social status characteristics, information on main risk factors, biochemical indices, main clinical data and cumulative dose of the external exposure were evaluated. Using the sphygmograph VaSera VS-1500N (Japan) the following parameters of computer sphygmomanometry in the employees were analyzed : pulse and medium arterial pressure, aortic pulse wave velocity (PWV), cardio ankle vascular index (CAVI), anklebrachial pressure index (ABI).

Results: 48 people had hypertension of 1-2 degrees, 47 people had abdominal obesity, 81 people had dyslipidemia of the total number surveyed. Employees exposed to low levels of radiation did not have asymmetric occlusive and stenosing lesions of arterial system of the upper and lower limbs were not detected. The value of PWV and CAVI characterizing real vascular rigidity did not differ statistically and significantly in the compared groups (health individuals: patients with arterial hypertension; individuals with normal weight and individuals with obesity). Only patients with the second degree of arterial hypertension had the tendency of increasing of vascular rigidity. Perhaps this is due to the protective effect of low doses of ionizing radiation on the vascular wall. Methods of computer Sphygmometria complements the protocol of the periodic medical staff examination of radiation-hazardous facilities. If there are conventional risk factors for the progression of hypertension, occupational exposure is not a significant factor in the pathogenesis of the disease.

Conclusion: The analysis of computer sphygmomanometry parameters did not detect the negative influence of the external exposure in the studied dose range on the vascular wall in the individuals exposed to the occupational irradiation (external γ-radiation). Arterial hypertension pathogenesis of the able-bodied men of 44-55 years old was mainly connected with the increase in body size, abdominal obesity, dyslipidemia, elevation of vascular rigidity.

Key words: occupational irradiation, low doses, arterial hypertension, risk factors, vascular rigidity, computer sphygmomanometry

REFERENCES

  1. Semenova Yu.V., Karpov A.B., Litvinenko T.M. et al. Kontrol' faktorov riska serdechno-sosudistykh zabolevanii v real'noi klinicheskoi praktike. Vrach. 2014. No. 3. P. 85-87. (In Russ.).
  2. Conroy R.M., Pyörälä K., Fitzgerald A.P. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 2003. Vol. 24. P. 987-1003.
  3. 2012 European guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J., 2012. Vol. 33. P. 1635-1701.
  4. Drubay D., Caër-Lorho S., Laroche P. et al. Mortality from circulatory system diseases among French uranium miners: a nested case-control study. Radiat. 2015. Vol. 183. No. 5. P. 550-562.
  5. Karpov A.B., Semenova Yu.V., Takhauov R.M. et al. The risk of acute myocardial infarction and arterial hypertension in a cohort of male employees of Siberian Group of Chemical Enterprises exposed to long term irradiation. Health Phys. 2012. Vol. 103. No. 1. P. 15-23.
  6. Zablotska L.B., Little M.P., Cornett R.J. Potential increased risk of ischemic heart disease mortality with significant dose fractionation in the Canadian Fluoroscopy Cohort Study. Am. J. Epidemiol. 2014. No. 1. P. 120-131.
  7. Bychkovskaya I.B., Stepanov R.P., Kirik O.V. Nekotorye novye aspekty problemy radiochuvstvitel'nosti maloobnovlyayushchikhsya tkanei. Medical Radiology and Radiation Safety. 2003. Vol. 48. No. 6. P. 5-15. (In Russ.).
  8. Celermayer D.S. Endothelial dysfunction: Does it matter? Is it reversible? Am. Coll. Cardiol. 1998. Vol. 30. P. 325-332.
  9. Milyagin V.A., Milyagina I.V., Abramenkova N.Yu. et al. Neinvazivnye metody issledovaniya magistral'nykh sosudov. Smolensk: Smolenskaya gor. tipografiya. 2012. 223 p. (In Russ.).

For citation: Semenova YuV, Karpov AB, Takhauov RM, Borisova EG, Maximov DE, Trivozhenko AB, Kovalchuk E.V. Structural and Functional Changes of Vascular System in Individuals Exposed to Occupational Irradiation of Low Intensity. Medical Radiology and Radiation Safety. 2016;61(1):34-40. Russian.

PDF (RUS) Full-text article (in Russian)

Medical Radiology and Radiation Safety. 2016. Vol. 61. No. 1. P. 22-28

RADIATION SAFETY

A.L. Polyudin

Forms of Technogenic Uranium in the Soil of the Shore of the Lake Cinara, Kaslinsky District, Chelyabinsk Region

E.I. Zababakhin Russia Research Institute of Technical Physics, Snezhinsk, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

ABSTRACT

Purpose: To study the modes of occurrence, accumulation, distribution of uranium in the soil of the area of influence of Russian Federal Nuclear Center, to study the features, determining the peculiarities of the soil as the main storage medium.

Material and methods: Soil profiles were laid according to the elementary geochemical landscapes. In the samples consecutively selective recovery of physical and chemical forms of uranium and the subsequent analysis by spectrophotometry with the usage of tributyl phosphate and arsenazo III were carried out. Also soil acidity, redox potential, particle size distribution, soil density, the density of the solid phase of the soil were determined and filtration coefficient in the soil was calculated as well.

Results: Actual acidity is in the range from 5.5 to 7.4. Redox is in the range from 273 to 348 mV. The indicator shows the intensity of the processes (rH2), and characterizes the soil as an environment, periodically reducing atmosphere. Under these conditions uranium, has a strong migratory ability. And the elements that affect the ability of soils to capture the element (iron and manganese) are in transitional oxidation. The soils that were studied have an easy size distribution and bad detained pollutants, the predominant fraction of the soils is a fine sand (0.25-0.05 mm). Filtration coefficient can be assessed as a high one for the soil of the eluvial and transeluvial position and extremely high for the soil of the superaqual position. The uranium content was 20 mg/kg in the soil of the transeluvial position, its characterizing anthropogenic component in the soils of the transeluvial position came to 93 %. Uranium was concentrated mainly in the soils of the transeluvial position and tied to water-soluble carbonates and clay minerals. In the soils of the eluvial and superaqual position uranium is in a stable and minimal migration of the acid (tied to sesquioxide), and also in the remaining forms. Potentially movable mold of the total content of uranium is in the range of 25 to 89 %. The maximum content is observed at the depth of 20-25 cm in the form predominantly connected to the sesquioxide and mineral components of the soil. Potentially mobile forms in the structure of the extraction criterion is the content of the peak at the depth of 8-12 cm, owning to the forms of uranium tied to the water-soluble carbonates and clay minerals.

Key words: long-lived radionuclides, uranium, forms of occurrence, soil Emissions

REFERENCES

  1. Polyudin A.L., Faizrakhmanov F.F. Issledovanie kontsentratsii radionuklidov v vozdushnoi srede opytnykh polei pri gazodinamicheskikh issledovaniyakh. V sb.: «Promyshlennaya bezopasnost' i ekologiya». Sarov. 2010. P. 3-8. Razreshenie 2115. (In Russ.).
  2. SanPiN 2.6.1.07-03. Gigienicheskie trebovaniya k proektirovaniyu predpriyatii i ustanovok atomnoi promyshlennosti. Moscow: Atomizdat. 2003. 32 p. (In Russ.).
  3. Bezuglaya E.Yu. Meteorologicheskii potentsial i klimaticheskie osobennosti zagryazneniya vozdukha gorodov. Leningrad: Gidrometeoizdat. 1980. 183 p. (In Russ.).
  4. Malashenko A.V. Rak legkogo u shakhterov uranovykh rudnikov osadochnogo mestorozhdeniya // Med. radiol. i radiats. bezopasnost'. 2007. Vol. 50, no. 6. P. 10-12. (In Russ.).
  5. Evseeva L.S. Geokhimiya urana v zone gipergeneza. Moscow: Gos. publ. literatury v oblasti nauki i tekhniki. 1962. 239 p. (In Russ.).
  6. Andreeva O.S., Bad'in V.N., Kornilov A.N. Prirodnyi i obogashchennyi uran. Radiatsionno-gigienicheskie aspekty. Moscow: Atomizdat. 1979. 216 p. (In Russ.).
  7. Vinogradov A.P. Osnovnye cherty geokhimii urana. Moscow: AN SSSR. 1963. 352 p. (In Russ.).
  8. Mamontov V.G., Panov N.P., Kaurichev I.S. Obshchee pochvovedenie. Moscow: KolosS. 2006. 456 p. (In Russ.).
  9. Kozachenko V.P. Obosnovanie priemov ratsional'nogo ispol'zovaniya. obrabotki i melioratsii zemel' sel'skokhozyaistvennogo naznacheniya Chelyabinskoi oblasti. Chelyabinsk: ChelGU. 1999. 134 p. (In Russ.).
  10. Protasov N.A. Geokhimiya prirodnykh landshaftov. Voronezh. Poligraf. tsentr Voronezhskogo gos. un-ta. 2008. 36 p. (In Russ.).
  11. Dospekhov B.A. Metodika polevogo opyta. Moscow: Agropromizdat. 1985. 351 p. (In Russ.).
  12. Vadyunina A.F., Korchagina V.A. Metody opredeleniya fizicheskikh svoistv i gruntov. Moscow: Vysshaya shkola. 1961. 345 p. (In Russ.).
  13. Sinyavskii V.A. Fizicheskie, fiziko-khimicheskie i khimicheskie metody analiza v ekologii pochv. Chelyabinsk: ChelGU. 2004. 36 p. (In Russ.).
  14. Istochniki, effekty i opasnost' ioniziruyushchei radiatsii. Doklad nauchnogo komiteta OON po deistviyu atomnoi radiatsii General'noi assamblee za 1988 g. NKDAR OON. Moscow: Mir. 1993. 728 p. (In Russ.).
  15. Uralbekov B.M., Satybaldiev B.S., Nazarkulova Sh.N. Uran i radii v mineral'nykh sostavlyayushchikh pochv mestorozhdeniya Kurdai. V sb.: «Materialy mezhdunarodnoi konferentsii po analiticheskoi khimii i ekologii». Almaty: KazNU. 2010. P. 86-93. (In Russ.).
  16. Tessier A. Sequential extraction procedure for the speciation of particulate trace metals // Analit. Chem. 1979. Vol. 51. P. 844-851.
  17. Marei N.A., Zykova A.S. Metodicheskie rekomendatsii po sanitarnomu kontrolyu za soderzhaniem radioaktivnykh veshchestv v ob"ektakh vneshnei sredy. Moscow: Vtoraya tipografiya. 1980. 336 p. (In Russ.).
  18. Aleksakhin R.M., Arkhipov N.P., Barkhudarov R.M. Tyazhelye estestvennye radionuklidy v biosfere: migratsiya i biologicheskoe deistvie na populyatsii i biotsenozy. Moscow: Nauka. 1990. 368 p. (In Russ.).
  19. Kovalevskii A.L. O fiziologicheskikh bar'erakh pogloshcheniya u rastenii po otnosheniyu k bol'shim kontsentratsiyam urana v pitatel'noi srede. V sb.: «Teoreticheskie i prakticheskoe deistvie malykh doz ioniziruyushchei radiatsii». 1973. P. 92-94. (In Russ.).

For citation: Polyudin AL. Forms of Technogenic Uranium in the Soil of the Shore of the Lake Cinara, Kaslinsky District, Chelyabinsk Region. Medical Radiology and Radiation Safety. 2016;61(1):22-8. Russian.

PDF (RUS) Full-text article (in Russian)

  1. 2016-1-Rubtsov-eng
  2. 2016-1-Soloviev-eng
  3. 2016-2-Zhuntova-eng
  4. 2016-2-Sidorova-eng

Contact Information

 

46, Zhivopisnaya st., 123098, Moscow, Russia Phone: +7 (499) 190-95-51. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal location

Attendance

4005849
Today
Yesterday
This week
Last week
This month
Last month
For all time
6045
3887
19482
30856
135555
124261
4005849
Forecast today
6216

Your IP:216.73.217.31
Visitor Counter

© Журнал "Медицинская радиология и радиационная безопасность" 2020г.

Яндекс.Метрика

Наверх